Moody Aldrich Partners »

Avalo Therapeutics Ord shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 133k 18.16

More positions owned by Moody Aldrich Partners

Praxis Precision Medicines I Com New (PRAX)
Cadence Bank
Independent Bank (INDB)
Bridgebio Pharma (BBIO)
Columbia Banking System (COLB)
Wintrust Financial Corporation (WTFC)
Piper Jaffray Companies (PIPR)
Meta Financial (CASH)
Axsome Therapeutics (AXSM)
Portland Gen Elec Com New (POR)
Viatris (VTRS)
Karman Hldgs Common Stock (KRMN)
Protagonist Therapeutics (PTGX)
Element Solutions (ESI)
Modine Manufacturing (MOD)

View all positions for Moody Aldrich Partners

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
Silverarc Capital Management
RA Capital Management
Marshall Wace
Citadel Advisors
TCG Crossover Management
Commodore Capital
UBS Group

View all funds holding Avalo Therapeutics Ord